Dimensional Fund Advisors
TCRR

Dimensional Fund Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Dimensional Fund Advisors’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-171,214
Closed -$257K – 3551
2023
Q1 		$257K Sell
171,214
-38,904
-19% -$52.4K ﹤0.01% 3157
2022
Q4 		$209 Sell
210,118
-117,830
-36% -$159K ﹤0.01% 3220
2022
Q3 		$590K Buy
327,948
+196,555
+150% +$570K ﹤0.01% 3008
2022
Q2 		$381K Buy
131,393
+7,442
+6% +$18.4K ﹤0.01% 3124
2022
Q1 		$342K Sell
123,951
-2,585
-2% -$8.13K ﹤0.01% 3228
2021
Q4 		$590K Sell
126,536
-10,647
-8% -$66.6K ﹤0.01% 3132
2021
Q3 		$1.17M Sell
137,183
-308,632
-69% -$4.36M ﹤0.01% 3010
2021
Q2 		$7.32M Buy
445,815
+95,131
+27% +$1.92M ﹤0.01% 2481
2021
Q1 		$7.74M Buy
350,684
+236,154
+206% +$6.44M ﹤0.01% 2426
2020
Q4 		$3.54M Buy
114,530
+68,839
+151% +$1.74M ﹤0.01% 2640
2020
Q3 		$926K Buy
+45,691
New +$802K ﹤0.01% 2952

Dimensional Fund Advisors's TCRR Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 171,214 shares — an estimated $257K sold.

Dimensional Fund Advisors first reported a position in TCRR in Q3 2020 and held it in 11 quarters. The position peaked at $7.74M in Q1 2021. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 171,214 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $257K.
  • Dimensional Fund Advisors first reported a position in TCR2 Therapeutics Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Dimensional Fund Advisors's TCR2 Therapeutics Inc. Common Stock position peaked at $7.74M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.